Share on StockTwits
 

Equities Research Analysts’ ratings reiterations for Tuesday, January 28th:

Barrick Gold Corp (NYSE:ABX) had its buy rating reiterated by analysts at Deutsche Bank. The firm currently has a $25.00 price target on the stock.

BHP Billiton Limited (ASX:BHP) had its add rating reiterated by analysts at CIMB. The firm currently has a $42.80 price target on the stock.

Caterpillar (NYSE:CAT) had its neutral rating reissued by analysts at Zacks. They currently have a $96.00 target price on the stock. Zacks’ analyst wrote, “Caterpillar’s fourth-quarter revenues declined 10% year over year to $14.4 billion, while earnings per share increased 5% to $1.54 as the company’s incessant efforts to cut down costs helped mitigate the effect of lower mining-related sales on its profits. Caterpillar will benefit from increased share in the Chinese excavator market, recovery in the U.S. construction sector and share repurchases. However, a declining backlog, the European debt crisis remain concerns for the mining equipment behemoth. We maintain our Neutral recommendation with a target price of $96.00.”

Cardno Limited (ASX:CDD) had its reduce rating reiterated by analysts at Morningstar.

Comcast Corp. (NASDAQ:CMCSA) had its fair value rating reiterated by analysts at Janney Montgomery Scott.

Quest Diagnostics (NYSE:DGX) had its underperform rating reissued by analysts at Zacks. Zacks currently has a $49.00 price target on the stock. Zacks’ analyst wrote, “Quest Diagnostics reported a dismal third quarter 2013 with adjusted EPS of $1.02, lagging the Zacks Consensus Estimate by $0.02 and the year-ago earnings by 11.3%. Besides, revenues of $1.79 billion were down 1.9%, also failing to meet the Zacks Consensus Estimate. The current market environment continues to pose challenges in the form of lower health care utilization and Medicare cuts. We are also concerned with the overall soft industry trends leading to volume pressure as reflected in the conservative 2013 outlook. Although, we are positive on the company’s organizational restructuring initiative and the strategy to align assets in core diagnostics information service business, near-term visibility remains a matter of concern. Accordingly, we reiterate the stock at Underperform. “

Emera (TSE:EMA) had its outperform rating reaffirmed by analysts at CSFB. The firm currently has a C$36.00 price target on the stock.

Synageva BioPharma Corp. (NASDAQ:GEVA) had its buy rating reaffirmed by analysts at Goldman Sachs Group Inc..

Kohl’s Corp. (NYSE:KSS) had its neutral rating reiterated by analysts at Zacks. Zacks currently has a $53.00 target price on the stock. Zacks’ analyst wrote, “Kohl’s third quarter earnings of $0.81 per share lagged the Zacks Consensus Estimate and year- ago earnings by 5.8% and 11% respectively. Earnings did not even meet management’s expectation due to lower revenue and gross margins. Net sales fell 1.0% from the year-ago level due to lower comps. Sales also missed the Zacks Consensus Estimate due to a challenging retail environment. Gross and operating margins shrank due to lower revenues and higher operating expenses. Moreover, Kohl’s high inventory levels and rising commodity costs are concerns. However, we have faith in the company’s strong fundamentals. Despite weak quarterly results, the company has a solid brand portfolio. Moreover, its growing e-commerce business, a strong balance sheet, and impressive dividend yield make the stock attractive over the long term. Thus we prefer to remain on the sidelines with a Neutral recommendation.”

Mead Johnson Nutrition (NYSE:MJN) had its buy rating reaffirmed by analysts at Deutsche Bank. The firm currently has a $94.00 price target on the stock.

WM Morrison Supermarkets (LON:MRW) had its buy rating reiterated by analysts at Cantor Fitzgerald Europe. The firm currently has a GBX 330 ($5.44) target price on the stock.

WM Morrison Supermarkets (LON:MRW) had its buy rating reaffirmed by analysts at Cantor Fitzgerald Europe. Cantor Fitzgerald Europe currently has a GBX 330 ($5.44) price target on the stock.

Newcrest Mining Limited (ASX:NCM) had its buy rating reiterated by analysts at Morningstar.

Scorpio Bulkers (NASDAQ:SALT) had its buy rating reissued by analysts at Deutsche Bank. The firm currently has a $18.00 target price on the stock.

SCBT Financial Corp. (NASDAQ:SCBT) had its buy rating reissued by analysts at Wunderlich.

AT&T (NYSE:T) had its hold rating reiterated by analysts at Deutsche Bank. They currently have a $36.00 target price on the stock.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.